Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medx HealthMDXHF EV-to-EBITDA is -5.68 as of Aug. 23, 2026. The stock has 8 warning signs investors should review. Among 516 Medical Devices & Instruments companies, Medx Health ranks worse than 193798.26% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medx Health's enterprise value is $17.22 Mil.
Medx Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-3.03 Mil. Therefore, Medx Health's EV-to-EBITDA for today is -5.68.
The historical rank and industry rank for Medx Health's EV-to-EBITDA or its related term are showing as below:
MDXHF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -27.27 Med: -6.91 Max: -2.14
Current: -5.7
During the past 13 years, the highest EV-to-EBITDA of Medx Health was -2.14. The lowest was -27.27. And the median was -6.91.
MDXHF's EV-to-EBITDA is ranked worse than 100% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 14.65
vs MDXHF: -5.70
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Medx Health (OTCPK:MDXHF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medx Health's PE Ratio (TTM) for today is calculated as:
Medx Health's share price for today is $0.025.
Medx Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.007.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Medx Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medx Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medx Health EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medx Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Medx Health's EV-to-EBITDA falls into.
Medx Health's current Enterprise Value is $17.22 Mil.
Medx Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medx Health (MDXHF) has a EV-to-EBITDA of -5.68 as of Aug. 23, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medx Health. According to the industry distribution chart, Medx Health ranks #999999 out of 516 companies in the Medical Devices & Instruments industry.
Is Medx Health's EV-to-EBITDA too high?
Medx Health's current EV-to-EBITDA is -5.68. Based on the distribution chart, Medx Health ranks #999999 out of 516 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Medx Health's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medx Health ranks #999999 out of 516 companies for EV-to-EBITDA. This places Medx Health in the lower half of its industry. The industry median EV-to-EBITDA is 14.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.65, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medx Health. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medx Health's current EV-to-EBITDA is -5.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medx Health stock overvalued right now?
Based on GuruFocus' analysis, Medx Health (MDXHF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.03 — trading 150% above its estimated fair value. The current EV-to-EBITDA is -5.68. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Medx Health (MDXHF), the current EV-to-EBITDA is -5.68 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medx Health Corp is engaged in the development, manufacturing, and marketing skin-related screening tools and phototherapy devices for pain relief and tissue repair, marketing the latter in Canada and the United States while the skin related screening tools are also marketed in Europe, Australia and selected markets in Latin America. It offers DermSecure, and MedX Laser Therapy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDXHF has been successfully added to your 
